20 octubre 2014
Since studies are lacking, it remains unclear whether certain patients have a benefit if the decision for or against adjuvant chemotherapy is based on the concentration of uPA and PAI-1, a new report states.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/J3DjeEBXe84/141020105327.htm
